| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $111.3M | +0.5% |
| R&D Expense | $249.9M | +8.3% |
| SG&A Expense | $62.7M | -0.8% |
| Operating Income | -$201.3M | -9.8% |
| Pre-tax Income | -$191.8M | -7.8% |
| Income Tax | $429K | +40.2% |
| Net Income | -$192.3M | -7.8% |
| EPS (Basic) | -$1.25 | -1.6% |
| EPS (Diluted) | -$1.25 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.4M | -43.8% |
| Accounts Receivable | $3.7M | -38.8% |
| Current Assets | $300.3M | -24.7% |
| Total Assets | $562.5M | -22.1% |
| Current Liabilities | $111.7M | -12.6% |
| Total Liabilities | $267.6M | -22.8% |
| Stockholders' Equity | $295.0M | -21.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$223.6M | +4.1% |
| Capital Expenditures | $20.2M | -13.3% |
| Investing Cash Flow | $59.3M | -76.1% |
| Financing Cash Flow | $84.7M | +157.7% |
| Free Cash Flow | -$243.8M | +5.0% |
| -1.6% |